Author
Listed:
- Tamer M. A. Mohamed
(Institute of Cardiovascular Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, UK
J David Gladstone Research Institutes
Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt)
- Riham Abou-Leisa
(Institute of Cardiovascular Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, UK)
- Nicholas Stafford
(Institute of Cardiovascular Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, UK)
- Arfa Maqsood
(Institute of Cardiovascular Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, UK)
- Min Zi
(Institute of Cardiovascular Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, UK)
- Sukhpal Prehar
(Institute of Cardiovascular Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, UK)
- Florence Baudoin-Stanley
(Institute of Cardiovascular Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, UK)
- Xin Wang
(Faculty of Life Sciences, University of Manchester)
- Ludwig Neyses
(Institute of Cardiovascular Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, UK)
- Elizabeth J. Cartwright
(Institute of Cardiovascular Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, UK)
- Delvac Oceandy
(Institute of Cardiovascular Sciences, University of Manchester, AV Hill Building, Manchester M13 9PT, UK)
Abstract
The heart responds to pathological overload through myocyte hypertrophy. Here we show that this response is regulated by cardiac fibroblasts via a paracrine mechanism involving plasma membrane calcium ATPase 4 (PMCA4). Pmca4 deletion in mice, both systemically and specifically in fibroblasts, reduces the hypertrophic response to pressure overload; however, knocking out Pmca4 specifically in cardiomyocytes does not produce this effect. Mechanistically, cardiac fibroblasts lacking PMCA4 produce higher levels of secreted frizzled related protein 2 (sFRP2), which inhibits the hypertrophic response in neighbouring cardiomyocytes. Furthermore, we show that treatment with the PMCA4 inhibitor aurintricarboxylic acid (ATA) inhibits and reverses cardiac hypertrophy induced by pressure overload in mice. Our results reveal that PMCA4 regulates the development of cardiac hypertrophy and provide proof of principle for a therapeutic approach to treat this condition.
Suggested Citation
Tamer M. A. Mohamed & Riham Abou-Leisa & Nicholas Stafford & Arfa Maqsood & Min Zi & Sukhpal Prehar & Florence Baudoin-Stanley & Xin Wang & Ludwig Neyses & Elizabeth J. Cartwright & Delvac Oceandy, 2016.
"The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy,"
Nature Communications, Nature, vol. 7(1), pages 1-16, April.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11074
DOI: 10.1038/ncomms11074
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11074. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.